OÜ PharmaFour
CopyRegistry data
Legal status
Company ID
14518678VAT code
EE102129067Registered
03/07/2018Share capital
2,500.00 €Contacts
Company registration address
Website
-
C
AverageReliability
C - Average
+10 ** during past year
Number of employees
13Credit limit
20-30 k €Credit report
Company's financial performance and creditability assessment.+4.12 % ** during past year
Taxes
20.2KDebts
-+6.80 % ** during past year
Taxable turnover
1.0M
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 3,226,907 |
| 1,075,636 |
| 5,230 |
| 5,230 |
| 1,743 |
| -0.24 |
| -8.61 |
| 9.03 |
| 291,355 |
| 6.63 |
| 213,901 |
| 12.12 |
| 0.16 |
| -161,505 |
| 1,390,390 |
| 604,040 |
| 859,845 |
| 2023 |
|---|
| 3,364,198 |
| 1,121,399 |
| 32,328 |
| 32,328 |
| 10,776 |
| -0.23 |
| -12.51 |
| 9.56 |
| 321,717 |
| 7.88 |
| 265,214 |
| 12.49 |
| 0.96 |
| -129,177 |
| 1,615,695 |
| 646,557 |
| 869,454 |
| 2024 |
|---|
| 4,127,898 |
| 412,790 |
| 21,681 |
| 21,681 |
| 2,168 |
| -0.10 |
| -10.72 |
| 7.26 |
| 299,631 |
| 5.58 |
| 230,295 |
| 13.94 |
| 0.53 |
| -107,496 |
| 1,152,528 |
| 294,250 |
| 750,782 |
| 2024 |
|---|
| 4,127,898 |
| 412,790 |
| 21,681 |
| 21,681 |
| 2,168 |
| -0.10 |
| -10.72 |
| 7.26 |
| 299,631 |
| 5.58 |
| 230,295 |
| 13.94 |
| 0.53 |
| -107,496 |
| 1,152,528 |
| 294,250 |
| 750,782 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16840009Reg. date:
13/10/2023Turnover:
-No. of employees:
8Category:
Retail sale of pharmaceutical productsComp. code:
16009799Reg. date:
15/07/2020Turnover:
-No. of employees:
7Category:
Retail sale of pharmaceutical productsComp. code:
14988044Reg. date:
11/06/2020Turnover:
-No. of employees:
9Category:
Retail sale of pharmaceutical productsComp. code:
14945023Reg. date:
30/03/2020Turnover:
-No. of employees:
7Category:
Retail sale of pharmaceutical productsComp. code:
14933899Reg. date:
10/03/2020Turnover:
-No. of employees:
8